Tomas J. Heyman - Insider Trading & Ownership

Location
C/O Akero Therapeutics, Inc., 170 Harbor Way 3 Rd Floor, South San Francisco, CA
Summary
The estimated net worth of Tomas J. Heyman is at least $1.95M dollars as of June 5, 2025. Tomas J. Heyman is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $1.53M. Tomas J. Heyman is the Director of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $422K.
Signature
/s/ Jonathan Young, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Tomas J. Heyman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $1.53M -$201K -11.6% May 29, 2025
AKRO Akero Therapeutics, Inc. Director $422K Jun 3, 2025
IVVD Invivyd, Inc. Director May 23, 2023
OPTN OptiNose, Inc. Director May 21, 2025
XLO Xilio Therapeutics, Inc. Director Jun 12, 2023

Insider Transactions Reported by Tomas J. Heyman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.